ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,794Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 682

$1.08M Total Retail Price of All Prescriptions

Rank: 84 out of 682

833 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 833 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 833 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 13,632 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SIMVASTATIN 621 551 1 4
LOSARTAN POTASSIUM 600 546 2 20
AMLODIPINE BESYLATE 504 462 3 6
LEVOTHYROXINE SODIUM 477 403 4 3
LISINOPRIL 474 400 5 2
HYDROCODONE-ACETAMINOPHEN 413 352 S3 6 1
OMEPRAZOLE 338 270 7 5
PRAVASTATIN SODIUM 323 264 8 15
METFORMIN HCL ER 300 234 9 68
ATENOLOL 299 275 10 18
ZOLPIDEM TARTRATE 296 248 11 21
TAMSULOSIN HCL 285 238 12 33
ATORVASTATIN CALCIUM 259 230 13 11
TRAMADOL HCL 243 182 14 26
FINASTERIDE 242 209 15 131
HYDROCHLOROTHIAZIDE 228 210 16 12
METOPROLOL TARTRATE 226 198 17 10
ALENDRONATE SODIUM 212 187 18 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 174 19 34
GABAPENTIN 181 141 20 9
FUROSEMIDE 158 136 21 7
METOPROLOL SUCCINATE 151 141 22 16
TRIAMTERENE-HCTZ 143 121 23 57
METFORMIN HCL 142 118 24 8
SERTRALINE HCL 142 137 24 24
NAMENDA 133 133 26 41
LOSARTAN-HYDROCHLOROTHIAZIDE 124 116 27 56
ALLOPURINOL 124 95 27 32
DONEPEZIL HCL 124 124 27 30
DILTIAZEM ER 123 123 30 136
POTASSIUM CHLORIDE 118 105 31 14
KLOR-CON M20 117 116 32 67
GLIPIZIDE ER 115 104 33 108
WARFARIN SODIUM 109 109 34 13
CLONAZEPAM 107 98 35 194
ISOSORBIDE MONONITRATE ER 106 92 36 31
PREDNISONE 106 102 36 40
CITALOPRAM HBR 105 94 38 17
CARVEDILOL 102 95 39 23
CLOPIDOGREL 101 79 40 25
ADVAIR DISKUS 88 84 41 47
FENOFIBRATE 87 79 42 76
GLIPIZIDE 87 66 42 61
SYNTHROID 85 74 44 59
DIOVAN 85 84 44 42
BENAZEPRIL HCL 84 59 46 89
CRESTOR 80 60 47 22
LOVASTATIN 79 72 48 66
FLUOXETINE HCL 75 27 49 60
PLAVIX 74 59 50 35
TRAZODONE HCL 72 52 51 38
PANTOPRAZOLE SODIUM 70 52 52 29
ALPRAZOLAM 68 48 53 90
LANTUS 68 56 53 55
CHLORTHALIDONE 67 62 55 182
MIRTAZAPINE 66 65 56 52
ATENOLOL-CHLORTHALIDONE 64 54 57 252
FLUTICASONE PROPIONATE 63 50 58 36
PAROXETINE HCL 63 43 58 53
NEXIUM 63 39 58 19
LANSOPRAZOLE 63 50 58 85
CIPROFLOXACIN HCL 62 56 62 58
MELOXICAM 60 57 63 27
DIGOXIN 60 48 63 46
SINGULAIR 57 43 65 63
BISOPROLOL FUMARATE 54 45 66 142
CLONIDINE 52 52 67 299
PROAIR HFA 52 41 67 45
OXYCODONE HCL-ACETAMINOPHEN 52 46 S2 67 98
ESCITALOPRAM OXALATE 52 38 67 73
EXFORGE HCT 51 47 71 381
CLONIDINE HCL 51 41 71 48
LOVAZA 50 49 73 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.